- Home
- CRWV vs RGC Comparison
CRWV vs RGC Comparison
Compare CRWV & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRWV
- RGC
- Stock Information
- Founded
- CRWV 2017
- RGC 2014
- Country
- CRWV United States
- RGC Hong Kong
- Employees
- CRWV N/A
- RGC N/A
- Industry
- CRWV
- RGC Medicinal Chemicals and Botanical Products
- Sector
- CRWV
- RGC Health Care
- Exchange
- CRWV NYSE
- RGC Nasdaq
- Market Cap
- CRWV 41.6B
- RGC 38.6B
- IPO Year
- CRWV 2025
- RGC 2021
- Fundamental
- Price
- CRWV $165.20
- RGC $21.38
- Analyst Decision
- CRWV Buy
- RGC
- Analyst Count
- CRWV 15
- RGC 0
- Target Price
- CRWV $75.31
- RGC N/A
- AVG Volume (30 Days)
- CRWV 21.5M
- RGC 2.5M
- Earning Date
- CRWV 08-14-2025
- RGC 06-30-2025
- Dividend Yield
- CRWV N/A
- RGC N/A
- EPS Growth
- CRWV N/A
- RGC N/A
- EPS
- CRWV N/A
- RGC N/A
- Revenue
- CRWV $2,708,374,000.00
- RGC N/A
- Revenue This Year
- CRWV $144.33
- RGC N/A
- Revenue Next Year
- CRWV $134.59
- RGC N/A
- P/E Ratio
- CRWV N/A
- RGC N/A
- Revenue Growth
- CRWV 17009.12
- RGC N/A
- 52 Week Low
- CRWV $33.52
- RGC $0.08
- 52 Week High
- CRWV $187.00
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- CRWV N/A
- RGC 46.54
- Support Level
- CRWV N/A
- RGC $9.39
- Resistance Level
- CRWV N/A
- RGC $34.58
- Average True Range (ATR)
- CRWV 0.00
- RGC 12.62
- MACD
- CRWV 0.00
- RGC -3.21
- Stochastic Oscillator
- CRWV 0.00
- RGC 9.47
About CRWV COREWEAVE INC
CoreWeave Inc is a modern cloud infrastructure technology company that offers the CoreWeave Cloud Platform which consists of proprietary software and cloud services that deliver the automation and efficiency needed to manage complex AI infrastructure at scale. Its platform supports the development and use of ground-breaking models and the delivery of the next generation of AI applications that are changing the way of living and working across the globe.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.